These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 32399093)

  • 21. Historical perspectives on the renin-angiotensin-aldosterone system and angiotensin blockade.
    Davis JO; Freeman RH
    Am J Cardiol; 1982 Apr; 49(6):1385-9. PubMed ID: 6280472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma renin activity to plasma aldosterone concentration ratio correlates with night-time and pulse pressures in essential hypertensive patients treated with angiotensin-converting enzyme inhibitors/AT1 blockers.
    Spannella F; Giulietti F; Balietti P; Borioni E; Lombardi FE; Ricci M; Cocci G; Landi L; Sarzani R
    J Hypertens; 2017 Nov; 35(11):2315-2322. PubMed ID: 28614094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The renin-angiotensin-aldosterone system: approaches to cardiac and renal therapy.
    Otte M; Spier A
    Compend Contin Educ Vet; 2009 Jan; 31(1):E1-7; quiz E7. PubMed ID: 19241351
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel therapies blocking the renin-angiotensin-aldosterone system in the management of hypertension and related disorders.
    Krum H; Gilbert RE
    J Hypertens; 2007 Jan; 25(1):25-35. PubMed ID: 17143168
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blood pressure lowering efficacy of renin inhibitors for primary hypertension.
    Musini VM; Fortin PM; Bassett K; Wright JM
    Cochrane Database Syst Rev; 2008 Oct; (4):CD007066. PubMed ID: 18843743
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RETRACTED: Relationship between the angiotensinogen A1166C gene polymorphism and the risk of diabetes mellitus developing into diabetic nephropathy.
    Yang CH; Zhou TB
    J Renin Angiotensin Aldosterone Syst; 2015 Dec; 16(4):NP45. PubMed ID: 28102727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retraction notice.
    J Renin Angiotensin Aldosterone Syst; 2015 Dec; 16(4):NP10. PubMed ID: 26699833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of the Renin-Angiotensin system mediates the effects of dietary salt intake on atherogenesis in the apolipoprotein E knockout mouse.
    Tikellis C; Pickering RJ; Tsorotes D; Huet O; Chin-Dusting J; Cooper ME; Thomas MC
    Hypertension; 2012 Jul; 60(1):98-105. PubMed ID: 22647892
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RETRACTED: Association of the ACE I/D gene polymorphism with sepsis susceptibility and sepsis progression.
    Yang CH; Zhou TB
    J Renin Angiotensin Aldosterone Syst; 2015 Dec; 16(4):NP51. PubMed ID: 28102726
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RETRACTED: Association between the ACE I/D gene polymorphism and T2DN susceptibility: The risk of T2DM developing into T2DN in the Asian population.
    Zhong W; Jiang Z; Zhou TB
    J Renin Angiotensin Aldosterone Syst; 2015 Dec; 16(4):NP35. PubMed ID: 28102725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RETRACTED: Association of the angiotensinogen M235T gene polymorphism with risk of diabetes mellitus developing into diabetic nephropathy.
    Tang W; Zhou TB; Jiang Z
    J Renin Angiotensin Aldosterone Syst; 2015 Dec; 16(4):NP27-NP34. PubMed ID: 28102723
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RETRACTED: Relationship between the ACE I/D gene polymorphism and T1DN susceptibility/risk of T1DM developing into T1DN in the Caucasian population.
    Zhou TB; Guo XF; Jiang Z; Li HY
    J Renin Angiotensin Aldosterone Syst; 2015 Dec; 16(4):NP18. PubMed ID: 28102722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renin Angiotensin Aldosterone System Inhibitors in Hypertension: Is There Evidence for Benefit Independent of Blood Pressure Reduction?
    Bavishi C; Bangalore S; Messerli FH
    Prog Cardiovasc Dis; 2016; 59(3):253-261. PubMed ID: 27777044
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of atrial natriuretic factor on blood pressure and the renin-angiotensin-aldosterone system.
    Atlas SA; Volpe M; Sosa RE; Laragh JH; Camargo MJ; Maack T
    Fed Proc; 1986 Jun; 45(7):2115-21. PubMed ID: 2940120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renin-angiotensin-aldosterone system inhibition: overview of the therapeutic use of angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, mineralocorticoid receptor antagonists, and direct renin inhibitors.
    Mercier K; Smith H; Biederman J
    Prim Care; 2014 Dec; 41(4):765-78. PubMed ID: 25439533
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypertension: renin-angiotensin-aldosterone system alterations.
    Te Riet L; van Esch JH; Roks AJ; van den Meiracker AH; Danser AH
    Circ Res; 2015 Mar; 116(6):960-75. PubMed ID: 25767283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New approaches to blockade of the renin-angiotensin-aldosterone system: overview of regulation of the renin-angiotensin-aldosterone system.
    Nishiyama A; Kim-Mitsuyama S
    J Pharmacol Sci; 2010; 113(4):289-91. PubMed ID: 20675960
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gastrointestinal potassium binding-more than just lowering serum [K(+)]: patiromer, potassium balance, and the renin angiotensin aldosterone axis.
    Emmett M; Mehta A
    Kidney Int; 2016 Sep; 90(3):484-6. PubMed ID: 27521112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renin-Angiotensin-Aldosterone Inhibitors and COVID-19.
    Benenson I; Waldron FA
    J Nurse Pract; 2020; 16(7):545-546. PubMed ID: 32834792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Captopril in primary hypertension. Effects related to the renin-angiotensin-aldosterone and kallikrein-kinin systems.
    Ohman KP; Karlberg BE; Nilsson OR; Wettre S
    Acta Med Scand Suppl; 1981; 646():98-105. PubMed ID: 7018190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.